Home / Health / WHO: Cervical Cancer Can Be First Cancer Eliminated
WHO: Cervical Cancer Can Be First Cancer Eliminated
19 Nov
Summary
- WHO aims to eliminate cervical cancer as a public health problem.
- The 90-70-90 targets focus on vaccination, screening, and treatment.
- Low-income countries face the highest burden of cervical cancer.
Eliminating cervical cancer as a public health problem is now within reach, according to the World Health Organization (WHO). This goal hinges on strengthening human papillomavirus (HPV) vaccination, screening, and treatment. The global health community is optimistic, given the availability of effective prevention tools.
More than 600,000 women are diagnosed with cervical cancer annually, and around 280,000 die from it. The burden is highest in low- and middle-income nations, where limited access to healthcare exacerbates the risk. Almost 20 of the 20 countries with the highest cervical cancer rates are in Africa.
In 2020, WHO Member States adopted a global strategy with the 90-70-90 targets. These aim for 90% of girls vaccinated against HPV by age 15, 70% of women screened by ages 35-45, and 90% of women with precancerous or invasive cancer receiving treatment.
Countries like Australia and Sweden are nearing elimination, while Rwanda shows progress in Africa. HPV vaccination is key, preventing infections that lead to cancer. Regular screening detects precancerous changes, with advancements like HPV DNA testing and self-sampling improving detection and convenience.
Artificial intelligence (AI) is also emerging as a tool for early detection and screening, analyzing images for suspicious tissue changes. However, experts emphasize that technology must complement, not replace, established prevention strategies.
Sustained investment in vaccination programs, expanded screening facilities, and accessible treatment are crucial. Affordability of vaccines, tests, and treatments for low- and middle-income countries is essential for global elimination. The message to women remains clear: vaccination, regular screening, and timely medical consultation significantly reduce risk.